Literature DB >> 1712445

A 43 kD c-mos protein is only expressed before meiosis during rat spermatogenesis.

F A van der Hoorn1, J E Spiegel, M F Maylié-Pfenninger, S K Nordeen.   

Abstract

We have investigated the RNA and protein expression pattern of the rat c-mos proto-oncogene during spermatogenesis. In mouse testis a 43kD c-mos protein is expressed throughout spermatogenesis, which is in agreement with one report detecting a 1.7 kb c-mos RNA in pachytene spermatocytes and in early spermatids. However, several other reports show that the mouse 1.7 kb c-mos RNA is exclusively expressed in post-meiotic male germ cells. We report that in rat male germ cells three c-mos RNA species of 5, 3.6 and 1.7 kb are detectable by Northern blotting analysis both before and after meiosis, with highest levels in early spermatids. However, western immuno-blot analysis reveals the presence of a 43 kD c-mos protein in total testis and pachytene spermatocytes, but not in post-meiotic cells. These findings combined with those made in the mouse system strongly suggest that c-mos protein may be a regulator of meiosis during spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712445

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  3 in total

1.  Testis-specific mak protein kinase is expressed specifically in the meiotic phase in spermatogenesis and is associated with a 210-kilodalton cellular phosphoprotein.

Authors:  A Jinno; K Tanaka; H Matsushime; T Haneji; M Shibuya
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

2.  Cytostatic factor proteins are present in male meiotic cells and beta-nerve growth factor increases mos levels in rat late spermatocytes.

Authors:  Marie-Hélène Perrard; Emeric Chassaing; Guillaume Montillet; Odile Sabido; Philippe Durand
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

3.  Suppression of DNA replication via Mos function during meiotic divisions in Xenopus oocytes.

Authors:  N Furuno; M Nishizawa; K Okazaki; H Tanaka; J Iwashita; N Nakajo; Y Ogawa; N Sagata
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.